PharmaDirections’ Pharmaceutical Formulation Development Expert to Speak at North Carolina Pharmaceutical Discussion Group

Share Article

PharmaDirections, a pharmaceutical consulting and project management company, is pleased to announce that Dr. Bruce Rehlaender, Director of Formulation Development, will be a key speaker at the 4th Annual Winter Event of the North Carolina Pharmaceutical Discussion Group. The theme of the meeting is “SUCCESSFUL API, DRUG PRODUCT DEVELOPMENT AND REGULATORY STRATEGIES”

Expert in Formulation Development

Dr. Bruce Rehlaender

Bruce really understands formulation development. His scientific approach to solving formulation problems is impressive.

Past News Releases

RSS

Dr. Bruce Rehlaender will speak on “Approaches to Overcoming Insoluble Drug Formulation Issues.” Dr. Rehlaender is an expert in biopharmaceutics and formulation of poorly soluble drugs. With over 20 years experience in pharmaceutical research and development, he has worked primarily in the arena of formulation development. His experience includes working with both small and large molecules, and in developing products for oral, parenteral, topical, pulmonary, intranasal, and intrauterine delivery.

This is a great opportunity to network with the local biotech community and learn some valuable information on formulation development and regulatory strategies.

The meeting will be held at Southport, 140 Southcenter Ct., Suite 600, Morrisville, NC from 11:30 – 6:00 PM. For more information contact Justin Pittman at PharmaDirections.

About PharmaDirections

PharmaDirections is a pharmaceutical consulting and project management company that focuses on solving problems in drug development. The main areas of practice include CMC, preclinical, and regulatory guidance with exceptional experience in formulation development and manufacturing. Providing services from technical advice to a total R&D team for hire, the overall advantage is that PharmaDirections’ clients maintain a lean organization while still achieving the highest scientific standards possible in developing viable pharmaceutical products.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Justin Pittman
Visit website